Compare MDXG & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | KIDS |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 625.6M | 512.4M |
| IPO Year | 2007 | 2016 |
| Metric | MDXG | KIDS |
|---|---|---|
| Price | $4.14 | $21.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $9.00 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 1.5M | 148.0K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $418,630,000.00 | $98,049,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | $13.02 | $11.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 19.99 | ★ 37.95 |
| 52 Week Low | $3.03 | $14.42 |
| 52 Week High | $7.97 | $22.80 |
| Indicator | MDXG | KIDS |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 67.34 |
| Support Level | $4.09 | $15.66 |
| Resistance Level | $4.45 | N/A |
| Average True Range (ATR) | 0.20 | 1.05 |
| MACD | -0.02 | 0.15 |
| Stochastic Oscillator | 56.55 | 89.75 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.